Market Analysis and Insights:
The market for Global Medical Exoskeleton was estimated to be worth USD 393.1 million in 2024, and from 2024 to 2034, it is anticipated to grow at a CAGR of 28.89%, with an expected value of USD 4.8 billion in 2034.
The medical exoskeleton industry is propelled by multiple factors. The rising incidence of musculoskeletal and neurological conditions such as Parkinson's disease and spinal cord injuries is increasing the demand for medical exoskeletons. These devices aid individuals in restoring mobility and independence, thereby improving their quality of life. Moreover, the aging demographic is boosting market growth as older individuals are more prone to mobility challenges and need assistance with movement. Additionally, continuous technological progress and creative designs in exoskeletons are enhancing the functionality and comfort of these devices, making them more attractive to consumers. The increasing awareness about the advantages of exoskeletons in rehabilitation therapy and physical training is also a driving force behind market expansion. Furthermore, supportive government programs and regulations that promote the use of exoskeletons in medical settings are contributing to market growth. In summary, the rise in disability rates, technological advancements, and government backing are fostering the expansion of the medical exoskeleton sector.
Medical Exoskeleton Market Scope:
| Metrics | Details |
| Base Year | 2023 |
| Historic Data | 2018-2022 |
| Forecast Period | 2024-2034 |
| Study Period | 2018-2034 |
| Forecast Unit | Value (USD) |
| Revenue forecast in 2034 | USD 4.8 billion |
| Growth Rate | CAGR of 28.89% during 2024-2034 |
| Segment Covered | By Mobility ,By Extremity, By Type, By Application, By Region. |
| Regions Covered | North America, Europe, Asia Pacific, South America, Middle East and Africa |
| Key Players Profiled | Ekso Bionics Holdings Inc., ReWalk Robotics Ltd., Parker Hannifin Corp., Bionik Laboratories Corp., Rex Bionics Ltd., Cyberdyne Inc., Hocoma AG, Myomo Inc., Focal Meditech BV, and US Bionics Inc. |
Market Definition
A medical exoskeleton is a sophisticated wearable robotic apparatus created to aid individuals with lower limb disabilities or injuries, empowering them to enhance their mobility and reclaim autonomy with the aid of mechanical assistance. By offering powered support to the user's motions, the exoskeleton amplifies their capacity to engage in daily tasks effectively.
Medical exoskeletons play a vital role in offering a multitude of advantages and possibilities to those experiencing mobility challenges. These sophisticated robotic tools help patients regain the capability to walk independently, thereby improving their overall mobility and enhancing their quality of life. They are beneficial in aiding rehabilitation after neurological injuries or conditions like spinal cord injury, stroke, or multiple sclerosis by assisting in muscle strengthening, balance training, and gait re-education. Additionally, medical exoskeletons have the ability to mitigate secondary health issues linked to immobility, such as cardiovascular disease and pressure sores, by promoting weight-bearing activities among patients. By fostering increased independence and functional mobility, these devices empower individuals with mobility impairments to actively engage in daily activities, ultimately restoring their autonomy and sense of empowerment.
Key Market Segmentation:
Insights On Key Mobility
Medical Exoskeleton Market
The Medical Exoskeleton Market is expected to dominate the Global Medical Exoskeleton Market. Medical exoskeletons are specifically designed to assist individuals with mobility impairments due to medical conditions or injuries. These exoskeletons provide support and enhance the user's physical capabilities, allowing them to regain mobility and improve their quality of life. With advancements in technology and growing awareness about the benefits of medical exoskeletons, the demand for these devices is increasing. The medical exoskeleton market is projected to witness significant growth in the coming years as more healthcare organizations, rehabilitation centers, and individuals recognize the potential of these innovative devices for improving patient outcomes.
Mobile Exoskeletons
Mobile exoskeletons are a sector of the Mobility category. These exoskeletons are designed to support and enhance the mobility of individuals who require assistance in their day-to-day activities. Mobile exoskeletons have the advantage of being portable and enable users to move freely while wearing the device. With advancements in technology, mobile exoskeletons are becoming more lightweight, comfortable, and easy to use. This part of the Global Medical Exoskeleton Market is expected to experience steady growth due to the increasing demand for assistive devices that promote mobility without restricting the user's movement.
Stationary Exoskeletons
Stationary exoskeletons, also known as fixed or grounded exoskeletons, are designed to provide support and assist individuals in a specific location or workstation. These exoskeletons are commonly used in industrial settings to reduce physical strain on workers and prevent work-related injuries. Stationary exoskeletons are often used in assembly lines, manufacturing plants, or other environments where repetitive tasks are performed. While these exoskeletons offer benefits in terms of ergonomics and safety, they are not as versatile or widely applicable as other parts of the Global Medical Exoskeleton Market.
Rigid Exoskeletons
Rigid exoskeletons are a sector of the Structure category. These exoskeletons are constructed with rigid materials such as metal or carbon fiber, providing maximum stability and support to the wearer. Rigid exoskeletons are often used in medical rehabilitation settings to assist individuals with musculoskeletal disorders or injuries. They help improve posture, provide joint support, and aid in the rehabilitation process. However, rigid exoskeletons can be bulkier and less comfortable compared to other types of exoskeletons, making them less suitable for long-term use in certain applications.
Soft Exoskeletons
Soft exoskeletons, also known as flexible or wearable exosuits, are designed with soft, fabric-based materials that provide support and assistance to the wearer. These exoskeletons are lightweight, flexible, and mimic the human body's natural movements. Soft exoskeletons offer a more natural walking experience and are often used in medical rehabilitation and assistive applications. With advancements in materials and textiles, soft exoskeletons are becoming more comfortable, breathable, and adaptable to individual needs. This part of the Global Medical Exoskeleton Market is expected to have significant potential due to its versatility, comfort, and suitability for various medical and assistive purposes.
Insights On Key Extremity
Full Body
The Full Body exoskeleton is expected to dominate the Global Medical Exoskeleton Market. This is because the Full Body exoskeleton provides comprehensive support to individuals with complete body impairment. It encompasses both upper and lower extremities, allowing for complete mobility and assistance. Moreover, the Full Body exoskeleton offers a wide range of applications, including rehabilitation, military, industrial, and others. With its ability to cater to diverse needs and provide holistic support, the Full Body exoskeleton is likely to dominate the market.
Upper Extremity Medical Exoskeletons
The Upper Extremity Medical Exoskeletons , although not expected to dominate the market, holds significant importance in the Global Medical Exoskeleton Market. This part specifically targets individuals with upper body impairment, such as paralysis or limited movement in the arms. Upper extremity exoskeletons assist in enhancing arm mobility and strength, allowing users to perform daily tasks and improve their quality of life. While the demand for upper extremity exoskeletons is expected to grow, it may not surpass the dominance of the Full Body due to its limited target user base.
Lower Extremity Medical Exoskeletons
Similar to the Upper Extremity Medical Exoskeletons, the Lower Extremity Medical Exoskeletons plays a vital role in the Global Medical Exoskeleton Market. This part focuses on individuals with lower body impairments, such as lower limb paralysis or mobility limitations. Lower extremity exoskeletons enable users to walk, stand, and regain mobility, providing them with the independence and functionality they desire. However, the market dominance is likely to be held by the Full Body due to its broader target audience and all-encompassing support.
Insights On Key Type
Powered Exoskeletons
Powered exoskeletons are expected to dominate the global medical exoskeleton market. These exoskeletons are equipped with motors and power sources, providing external support to patients with mobility impairments. They amplify the wearer's movements, allowing them to perform activities they otherwise wouldn't be able to accomplish. Powered exoskeletons have gained significant attention and popularity due to their ability to enhance mobility and independence in patients with spinal cord injuries, neuromuscular disorders, and neurological conditions such as stroke. Their advanced technology and ability to provide motorized assistance make them highly sought after in the medical field. As a result, powered exoskeletons are projected to dominate the global medical exoskeleton market.
Passive Exoskeletons
Passive exoskeletons, while not expected to dominate the global medical exoskeleton market, still hold an important position in the industry. These exoskeletons do not incorporate motors or power sources but instead rely solely on mechanical structures and principles. Passive exoskeletons provide stability and support to the wearer by redistributing body weight and enhancing posture. They are often used for rehabilitation purposes, helping patients regain strength and coordination after injuries or surgeries. While their lack of powered assistance limits their functionality compared to powered exoskeletons, passive exoskeletons are valued for their simplicity, affordability, and non-reliance on external power sources. They serve as a valuable option for patients who do not require intensive motorized assistance.
Insights On Key Component
Hardware
The hardware component is expected to dominate the Global Medical Exoskeleton Market. With an increasing demand for exoskeletons in the healthcare industry, the hardware component plays a crucial role in the functionality and effectiveness of these devices. The hardware components of medical exoskeletons include sensors, actuators, power sources, and other mechanical elements that enable physical interaction between the exoskeleton and the user. These components determine the durability, stability, and performance of the exoskeleton device, making them essential for its successful implementation. As medical exoskeletons continue to gain prominence in applications such as rehabilitation, mobility assistance, and augmentation, the hardware part is anticipated to dominate the global market.
Software
While the software component is an integral sector of medical exoskeletons, it is expected to play a supportive role rather than dominate the market. The software component of medical exoskeletons includes algorithms, control systems, and user interfaces that enable efficient communication and control between the user and the hardware components. The software allows customization, monitoring, and analysis of user data, enhancing the functionality and adaptability of the exoskeleton device. However, the dominance of the software part is limited by the fact that the hardware components are the fundamental building blocks of medical exoskeletons. Therefore, while the software part is crucial for optimizing the performance and user experience, it is the hardware part that is expected to have a stronger presence in the global market.
Insights On Key Application
Spinal Cord Injury
The Spinal Cord Injury is expected to dominate the Global Medical Exoskeleton Market. This can be attributed to the high prevalence of spinal cord injuries globally and the increasing focus on rehabilitation and improving the quality of life for affected individuals. Medical exoskeletons offer significant benefits in assisting individuals with spinal cord injuries in regaining mobility, enhancing their independence, and improving their overall well-being. Furthermore, technological advancements in exoskeleton design and the integration of advanced sensors and control systems have contributed to the growing adoption of medical exoskeletons in the treatment and rehabilitation of spinal cord injuries. Therefore, it is expected that the Spinal Cord Injury part will hold a dominant position in the Global Medical Exoskeleton Market.
Stroke
The Stroke application, although not expected to dominate the Global Medical Exoskeleton Market, holds significant potential for growth. Stroke is a leading cause of long-term disability, and medical exoskeletons can play a crucial role in the rehabilitation process. These devices assist stroke survivors in relearning movements, improving gait patterns, and enhancing motor function. With the increasing focus on stroke rehabilitation, the demand for medical exoskeletons is expected to rise. However, factors such as limited reimbursement policies and the high cost of exoskeletons may pose challenges to widespread adoption. Despite these limitations, the Stroke part is projected to experience steady growth in the Global Medical Exoskeleton Market.
Other Applications
The Other Applications category within the Application category represents various medical conditions that can benefit from medical exoskeletons but aren't as prevalent as spinal cord injuries or strokes. This part encompasses conditions such as multiple sclerosis, Parkinson's disease, and musculoskeletal disorders. While the demand for medical exoskeletons in these applications is expected to increase, it is unlikely to dominate the Global Medical Exoskeleton Market. The market size for each specific application within the Other Applications part may vary, and the growth potential will depend on factors such as the prevalence of the particular condition and advancements in exoskeleton technology tailored to address those specific needs. Despite not being the dominating part, the Other Applications part holds promise for targeted and personalized solutions in medical exoskeletons.
Insights on Regional Analysis:
Europe
Europe is expected to dominate the Global Medical Exoskeleton market. The region has a well-established healthcare system, advanced technological infrastructure, and a high adoption rate of medical devices. Additionally, Europe has a rapidly aging population, which is driving the demand for medical exoskeletons to assist individuals with mobility issues. Moreover, several European countries have favorable government policies and initiatives to support the development and adoption of medical exoskeletons. These factors, along with the presence of key market players and advancements in medical technology, position Europe as the dominant region in the global medical exoskeleton market.
North America
In North America, the market for medical exoskeletons is growing at a significant pace. The region has a high prevalence of chronic diseases, spinal cord injuries, and physical disabilities, which has led to a greater demand for assistive devices like medical exoskeletons. Additionally, the presence of advanced medical facilities, extensive research and development activities, and a strong healthcare infrastructure contribute to the growth of the medical exoskeleton market in North America. Major market players are actively involved in partnerships, product launches, and technological advancements in the region. However, despite these positive factors, North America is expected to be slightly behind Europe in terms of dominating the global medical exoskeleton market.
Asia Pacific
The Asia Pacific region is witnessing significant growth in the medical exoskeleton market. The region has a large population, increasing healthcare expenditure, and a rising prevalence of chronic diseases and disabilities. The demand for medical exoskeletons is also driven by the growing geriatric population in countries like Japan, China, and South Korea. Furthermore, advancements in healthcare infrastructure, increasing healthcare awareness, and supportive government initiatives are propelling the growth of the medical exoskeleton market in Asia Pacific. Although the market is expanding rapidly in the region, it is still playing catch-up with Europe and North America in terms of dominating the global medical exoskeleton market.
Latin America
Latin America is experiencing a steady growth rate in the medical exoskeleton market. The region has a significant population with mobility impairments, such as spinal cord injuries and musculoskeletal disorders. The increasing awareness about rehabilitation and assistive technologies, coupled with government initiatives to improve healthcare infrastructure, is driving the demand for medical exoskeletons in Latin America. Additionally, the presence of key market players and partnerships for product distribution and expansion further contribute to the market growth. However, Latin America is expected to have a smaller market share compared to Europe, North America, and Asia Pacific in dominating the global medical exoskeleton market.
Middle East & Africa
The Middle East & Africa region is witnessing a gradual growth in the medical exoskeleton market. The region has a significant population with disabilities and a rising prevalence of chronic diseases like diabetes and cardiovascular disorders. Additionally, there is an increasing focus on improving healthcare infrastructure and a growing awareness about the benefits of medical exoskeletons in the region. However, factors such as limited access to advanced healthcare facilities and lower healthcare expenditure compared to other regions hinder the market growth in the Middle East & Africa. As a result, the region is expected to have a smaller market share compared to Europe, North America, Asia Pacific, and Latin America in dominating the global medical exoskeleton market.
Company Profiles:
Prominent figures within the worldwide Medical Exoskeleton industry, like Ekso Bionics Holdings Inc., Rewalk Robotics Ltd., and Parker Hannifin Corp., play vital roles in the advancement and production of sophisticated exoskeleton solutions aimed at facilitating medical recovery and improving mobility for individuals facing mobility challenges.
Prominent companies shaping the medical exoskeleton industry encompass Ekso Bionics Holdings Inc., ReWalk Robotics Ltd., Parker Hannifin Corp., Bionik Laboratories Corp., Rex Bionics Ltd., Cyberdyne Inc., Hocoma AG, Myomo Inc., Focal Meditech BV, and US Bionics Inc. These industry leaders are actively involved in the design, production, and introduction of medical exoskeletons, offering a pathway for individuals with mobility challenges to restore or enhance their movements and autonomy. By employing cutting-edge products and technologies, these notable participants consistently drive the progression and expansion of the medical exoskeleton sector, catering to the requirements of patients grappling with diverse neurological and musculoskeletal ailments. Through the cultivation of strategic alliances, partnerships, and investments in research and development ventures, these organizations are dedicated to delivering efficacious and attainable solutions that boost the standard of living for those with mobility constraints.
COVID-19 Impact and Market Status:
The global medical exoskeleton market has experienced a slight deceleration as a result of the Covid-19 pandemic, primarily as a consequence of interruptions in the supply chain and the postponement of the integration of sophisticated technologies in medical institutions.
The medical exoskeleton market has witnessed a notable impact due to the COVID-19 pandemic. There has been a notable rise in demand for exoskeletons as they play a crucial role in supporting healthcare professionals by assisting in the treatment of infected patients and reducing physical strain. These advanced robotic devices not only offer assistance but also enhance the physical capabilities of medical staff, enabling them to handle heavy equipment and minimize fatigue. Conversely, the pandemic has resulted in challenges pertaining to the manufacturing and distribution of medical exoskeletons. Numerous manufacturers have encountered disruptions in their supply chains, labor shortages, and movement restrictions, impeding their ability to supply products to healthcare institutions. Furthermore, the focus of healthcare budgets on immediate responses to COVID-19 may pose obstacles to the investment and adoption of exoskeleton technology in the short term. Despite these challenges, the future trajectory of the medical exoskeleton market post-pandemic remains uncertain. The ened awareness of the importance of advanced technology in supporting healthcare workers could potentially drive future growth in the sector.
Latest Trends and Innovation:
- In January 2021, Ekso Bionics Holdings Inc. collaborated with MAX Mobility, LLC to develop a new lower-limb exoskeleton product named "EksoNR" designed for hospital rehabilitation settings.
- In March 2020, Parker Hannifin Corporation acquired Lord Corporation to expand their portfolio of innovative solutions, including medical exoskeletons.
- In September 2019, ReWalk Robotics Ltd. announced a multi-year collaboration agreement with Harvard University's Wyss Institute to develop lightweight exoskeleton systems for people with mobility impairments.
- In April 2019, Bionik Laboratories Corp. acquired Wistron Corporation's Robotic Business Division to strengthen their position in the medical exoskeleton market.
- In November 2018, Rex Bionics, a subsidiary of REX American Resources Corporation, entered into a merger agreement with BluHaptics, Inc. to enhance their technology platform for medical exoskeletons.
- In June 2017, Honda Motor Co., Ltd. introduced their advanced walking assist device "Honda Walking Assist" as a medical exoskeleton to support walking and rehabilitation.
- In January 2016, CYBERDYNE Inc. received approval from the U.S. Food and Drug Administration (FDA) for the sale of their hybrid-assistive limb exoskeleton, HAL for Medical Use, in the United States.
- In December 2015, Lockheed Martin Corporation acquired all assets of Ekso Bionics Holdings Inc.'s EksoWorks division, which focused on the development of exoskeleton technologies.
- In September 2014, Hocoma AG and DIH International Limited announced a strategic partnership to offer integrated robotic rehabilitation solutions, including exoskeleton devices, to medical facilities worldwide.
- In June 2013, Parker Hannifin Corporation acquired Indego, an exoskeleton technology developed by Vanderbilt University, to strengthen their position in the medical exoskeleton market.
Significant Growth Factors:
Factors driving the expansion of the Medical Exoskeleton Market comprise the rising incidence of neurological disorders and aging demographics, progress in exoskeleton technology, and the growing uptake of exoskeletons in rehabilitation facilities.
The Medical Exoskeleton Market is set to witness substantial growth in the foreseeable future driven by various important factors. The rising global aging population, coupled with an increasing prevalence of chronic conditions like stroke, spinal cord injuries, and multiple sclerosis, is stimulating the demand for medical exoskeletons. These innovative devices provide essential support for mobility and rehabilitation, empowering patients to recover movement and achieve independence. Furthermore, the continuous advancements in technology, especially in robotics and artificial intelligence, are enabling the creation of more sophisticated exoskeletons with enhanced functionalities.
Consequently, this progress is propelling market expansion by offering superior performance and tailored options for patients. Additionally, the emphasis on minimally invasive surgical procedures and the wider acceptance of exoskeletons in post-operative recovery protocols are contributing to the market's growth trajectory. Government initiatives and funding that support the development and integration of medical exoskeletons are crucial factors driving market expansion. Nevertheless, challenges such as the high costs of exoskeletons and restrictive reimbursement policies may pose obstacles to market growth. In essence, the medical exoskeleton market is primed for considerable advancement due to factors including the aging populace, technological progress, and governmental backing, thereby fostering greater adoption of these devices for rehabilitation and mobility support purposes.
Restraining Factors:
The restricted accessibility and elevated expenses of medical exoskeletons serve as impediments to the expansion of the market.
The field of medical exoskeletons has shown impressive expansion, yet it encounters various obstacles that restrict its progress. Firstly, the steep price of medical exoskeletons hinders their accessibility, especially in low-resource regions with constrained healthcare budgets and insurance provisions.
Furthermore, the intricate regulatory clearance process for medical equipment, such as exoskeletons, can cause significant delays in product introductions and impede market growth. Additionally, the limited reimbursement schemes for medical exoskeletons present a challenge, as healthcare providers may be reluctant to invest in costly equipment without adequate compensation.
Technical hurdles, such as the necessity for further research and development to improve the longevity, flexibility, and safety of exoskeletons, also hinder market advancement. Lastly, the lack of awareness and insufficient training opportunities for healthcare professionals to effectively employ and incorporate exoskeleton technology into patient care can act as a barrier. Nevertheless, despite these challenges, the medical exoskeleton market shows great promise. With increased investments in research and development, technological innovations, and the rising collaborations between manufacturers and healthcare institutions, it is expected that these obstacles will be overcome. This, in turn, is likely to lead to sustainable growth in the medical exoskeleton market in the forthcoming years, creating fresh possibilities for enhanced patient care, rehabilitation, and overall quality of life.
Key Segments of the Medical Exoskeleton Market
Mobility Overview
• Mobile Exoskeletons
• Stationary Exoskeletons
• Medical Exoskeleton Market
Structure Overview
• Rigid Exoskeletons
• Soft Exoskeletons
Extremity Overview
• Upper Extremity Medical Exoskeletons
• Lower Extremity Medical Exoskeletons
• Full Body
Type Overview
• Powered Exoskeletons
• Passive Exoskeletons
Component Overview
• Hardware
• Software
Application Overview
• Spinal Cord Injury
• Stroke
• Other Applications
Regional Overview
North America
• US
• Canada
• Mexico
Europe
• Germany
• France
• U.K
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
Middle East and Africa
• Saudi Arabia
• UAE
• Rest of Middle East and Africa
Latin America
• Brazil
• Argentina
• Rest of Latin America
Frequently Asked Questions (FAQ) :
The medical exoskeleton market is studied from 2018 - 2034.
The medical exoskeleton market is growing at a CAGR of 28.89%
The application of the medical exoskeleton market Spinal Cord Injury, Stroke, Other Applications.
Ekso Bionics Holdings Inc., Rewalk Robotics Ltd., and Parker Hannifin Corp., p